| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
ZBIO sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.36M | $47.18M | - | |
| Other | 500.0K | - | - | |
| Other | 175.0K | - | - | |
| Other | 150.0K | - | - | |
| Other | 125.0K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 20, 2024 | Moulder Leon O Jr83 | Chief Executive Officer | Buy | 20,000 | $18.04 | $360,819.97 | +1.2% | -48.6% | -0.3% | |
| Sep 16, 2024 | Enavate Sciences Gp, LLC | 10% Owner | Buy | 882,353 | $17.00 | $15,000,001.00 | +30.6% | -51.2% | +1.5% | |
| Sep 16, 2024 | Nunn Jason Raleigh | Director | Buy | 882,352 | $17.00 | $14,999,984.00 | +387.2% | -51.2% | +1.5% | |
| Sep 16, 2024 | Sr One Capital Management, LLC52 | 10% Owner | Buy | 2,235,294 | $17.00 | $37,999,998.00 | -198.7% | -51.2% | +1.5% | |
| Sep 16, 2024 | Enright Patrick G75 | Director | Buy | 440,000 | $17.00 | $7,480,000.00 | +131.5% | -51.2% | +1.5% | |
| Sep 16, 2024 | Fairmount Funds Management LLC74 | Director | Buy | 300,000 | $17.00 | $5,100,000.00 | +23.0% | -51.2% | +1.5% | |
| Sep 13, 2024 | Lu Hongbo59 | Director | Buy | 58,823 | $17.00 | $999,991.00 | New | -49.0% | +11.5% |